Twist Bioscience's Chief Legal Officer Sold Over 14,000 Company Shares. What Does That Mean for Investors?
Written by Robert Izquierdo for The Motley Fool -> Dennis Cho sold 14,205 shares on May 29, 2026, for a total transaction value of ~$991,000, at a reported price of $69.75 per share. This transaction reduced Cho’s direct holdings from 134,299 shares to 120,094 shares. This sal
Dennis Cho sold 14,205 shares on May 29, 2026, for a total transaction value of ~$991,000, at a reported price of $69.75 per share.
This transaction reduced Cho’s direct holdings from 134,299 shares to 120,094 shares.
This sale is the largest single disposition in Cho’s 54 recent sales, reflecting both available share capacity and the stock’s 131.5% one-year gain as of the transaction date.
Chief Legal Officer Dennis Cho reported the sale of 14,205 shares of Twist Bioscience Corporation (NASDAQ:TWST) on May 29, 2026, for a transaction value of approximately $991,000, according to a SEC Form 4 filing .
Transaction value based on SEC Form 4 reported price ($69.75); post-transaction value based on holdings as valued using the May 29, 2026 close price.
* 1-year performance is calculated using May 29th, 2026 as the reference date.
Twist Bioscience Corporation is a leading synthetic biology company specializing in high-throughput DNA synthesis using a proprietary silicon-based platform. The company leverages its technology to provide scalable, cost-effective synthetic DNA products for research, diagnostics, and therapeutic development.
Strategic collaborations with major industry players and a focus on innovation position Twist Bioscience to address the growing demand for synthetic biology solutions across healthcare and biotechnology sectors.
